13F HOLDINGS REPORT
Frazier Life Sciences Management, L.P.
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001892134-25-000012
Total Value
$3.34B
Positions
47
Other Managers
0
Confidential Omitted
No
Holdings (47)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MIRUM PHARMACEUTICALS INC | MIRM | 6,795,121 | $498.2M | 14.93% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 16,701,956 | $475.0M | 14.23% |
| 3 | VERONA PHARMA PLC | 925050106 | 3,383,950 | $361.1M | 10.82% |
| 4 | BRIDGEBIO PHARMA INC | BBIO | 3,845,457 | $199.7M | 5.98% |
| 5 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 9,874,511 | $186.1M | 5.58% |
| 6 | PHATHOM PHARMACEUTICALS INC | PHAT | 12,466,489 | $146.7M | 4.40% |
| 7 | KRYSTAL BIOTECH INC | KRYS | 688,460 | $121.5M | 3.64% |
| 8 | MAZE THERAPEUTICS INC | MAZE | 4,567,274 | $118.4M | 3.55% |
| 9 | MBX BIOSCIENCES INC | MBX | 6,652,013 | $116.4M | 3.49% |
| 10 | DISC MEDICINE INC | IRON | 1,438,534 | $95.1M | 2.85% |
| 11 | TREVI THERAPEUTICS INC | TRVI | 10,259,409 | $93.9M | 2.81% |
| 12 | TARSUS PHARMACEUTICALS INC | TARS | 1,167,527 | $69.4M | 2.08% |
| 13 | KALVISTA PHARMACEUTICALS INC | KALV | 5,039,867 | $61.4M | 1.84% |
| 14 | ZAI LAB LTD | ZLAB | 1,627,320 | $55.1M | 1.65% |
| 15 | AGIOS PHARMACEUTICALS INC | AGIO | 1,279,754 | $51.4M | 1.54% |
| 16 | ERASCA INC | ERAS | 22,729,436 | $49.6M | 1.48% |
| 17 | CYTOKINETICS INC | CYTK | 890,445 | $48.9M | 1.47% |
| 18 | REVOLUTION MEDICINES INC | RVMDW | 997,455 | $46.6M | 1.40% |
| 19 | PALVELLA THERAPEUTICS INC NE | PVLA | 722,400 | $45.3M | 1.36% |
| 20 | SAVARA INC | SVRA | 11,462,301 | $40.9M | 1.23% |
| 21 | DYNE THERAPEUTICS INC | DYN | 2,718,105 | $34.4M | 1.03% |
| 22 | ABIVAX SA | AAVXF | 378,300 | $32.1M | 0.96% |
| 23 | AURA BIOSCIENCES INC | AURA | 5,100,000 | $31.5M | 0.94% |
| 24 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 983,715 | $29.6M | 0.89% |
| 25 | LEXEO THERAPEUTICS INC | LXEO | 4,424,725 | $29.4M | 0.88% |
| 26 | VALNEVA SE | VALN | 2,291,666 | $28.0M | 0.84% |
| 27 | AVIDITY BIOSCIENCES INC | 05370A108 | 625,000 | $27.2M | 0.82% |
| 28 | ASCENDIS PHARMA A/S | ASND | 133,333 | $26.5M | 0.79% |
| 29 | ALKERMES PLC | ALKS | 700,647 | $21.0M | 0.63% |
| 30 | MEREO BIOPHARMA GROUP PLC | MREO | 9,440,112 | $19.4M | 0.58% |
| 31 | AKERO THERAPEUTICS INC | 00973Y108 | 366,784 | $17.4M | 0.52% |
| 32 | VAXCYTE INC | PCVX | 474,405 | $17.1M | 0.51% |
| 33 | EVOLUS INC | EOLS | 2,630,665 | $16.2M | 0.48% |
| 34 | DESIGN THERAPEUTICS INC | DSGN | 1,953,547 | $14.7M | 0.44% |
| 35 | IMMUNOCORE HLDGS PLC | IMCR | 384,782 | $14.0M | 0.42% |
| 36 | ACADIA PHARMACEUTICALS INC | ACAD | 613,837 | $13.1M | 0.39% |
| 37 | JADE BIOSCIENCES INC | JBIO | 1,413,280 | $12.2M | 0.37% |
| 38 | ASSEMBLY BIOSCIENCES INC | ASMB | 456,249 | $11.7M | 0.35% |
| 39 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 2,077,431 | $9.4M | 0.28% |
| 40 | TRAVERE THERAPEUTICS INC | TVTX | 392,092 | $9.4M | 0.28% |
| 41 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 500,333 | $8.6M | 0.26% |
| 42 | ENGENE HOLDINGS INC | ENGNW | 1,157,380 | $7.9M | 0.24% |
| 43 | AUTOLUS THERAPEUTICS PLC | AUTL | 4,623,324 | $7.5M | 0.23% |
| 44 | MACROGENICS INC | MGNX | 3,175,665 | $5.3M | 0.16% |
| 45 | SILENCE THERAPEUTICS PLC | SLNCF | 970,130 | $5.0M | 0.15% |
| 46 | ALLOGENE THERAPEUTICS INC | ALLO | 3,868,750 | $4.8M | 0.14% |
| 47 | CRESCENT BIOPHARMA INC. | CBIO | 272,951 | $3.2M | 0.10% |